Alleviant Medical Secures $75M in Funding with Receives A FDA IDE Approval
Alleviant Medical, Inc., a privately held medical device company working on a no-implant interatrial shunt for heart failure, announced today the completion of a $75 million equity financing led by S3 Ventures and RiverVest Venture Partners. In this new financing round, S3 Ventures and RiverVest Venture Partners are joined by Gilmartin Capital, ShangBay Capital, and … Read more